Skip to main content
. 2024 Jun 3;14(3):905–913. doi: 10.1007/s44197-024-00232-6

Table 3.

Univariate analysis of factors affecting the regression of BE patients

Factor Exist group (n = 8) Dead group (n = 6) P
Age (year) 0.58
<40 2 25 3 50
≥40 6 75 3 50
Gender 0.02
Man 8 100 2 33.33
Women 0 0 4 66.67
Fever 0.59
Yes 5 62.5 2 33.33
No 3 37.5 4 66.67
HBG (g/L) 0.59
<90 3 37.5 4 66.67
≥90 5 62.5 2 33.33
Kidney injury
Yes 4 50 1 16.67
No 4 50 5
Valve involved 0.46
Mitral 4 50 2 33.33
Mitral + tricuspid 0 0 1 16.67
Aortic 4 50 3 50
Underlying heart disease 0.59
Yes 2 25 4 66.67
No 6 75 2 33.33
Cirrhosis 0 0 3 50 0.055
Chronic kidney disease 3 37.5 0 0 0.209
Heart failure 1
Yes 6 75 4 66.67
No 2 25 2 33.33
Size of vegetable (mm) 0.59
<15 3 37.5 2 33.33
≥15 5 62.5 4 66.67
Embolism 2 25 1 16.67 1
Surgery 0.14
Yes 5 62.5 1 16.67
No 3 37.5 5 83.33
Anti-infective 0.25
Yes 7 87.5 2 33.33
No 1 12.5 4 66.67
WBC (×109/L) 5.04±1.50 8.00±3.00 0.03
NEUT (×109/L) 3.43±1.03 6.39±2.91 0.02
PLT (×109/L) 95.5 (34.0, 237.75) 134 (34.0, 180.5) 0.84
PCT, ng/ml 0.31 (0.08, 1.02) 0.65 (0.27, 1.62) 0.53
CRP, mg/L 60.0 (23.61, 72.63) 51.48 (18.15, 101.76) 0.78
ESR, mm/h 28.0 (8.0, 47.0) 22.0 (15.0, 74.0)
ALT, U/L 23.5 (16.25, 85.05) 35.0 (19.0, 92.45) 0.73
ALB, g/L 25.66±5.14 26.06±7.31 0.91
TBIL, umol/L 12.8 (3.05, 22.03) 38.6 (20.5, 72.15) 0.04
Creatinine, umol/L 84.80 (52.0, 221.0) 71.43±17.50 0.30
BNP 739.55 (446.05, 2318.61) 523.40 (187.10, 610.85) 0.17

WBC, white blood cell; NEUT, neutrophil; PLT, platelet; HBG, Hemoglobin; PCT, procalcitonin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ALT, alanine aminotransferase; ALB, albumin; TBIL, total bilirubin; BNP, brain natriuretic peptide; INR, international normalized ratio